Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
3.76T | 3.71T | 3.59T | 3.59T | 3.86T | Gross Profit |
1.16T | 1.14T | 1.12T | 1.08T | 1.11T | EBIT |
260.21B | 335.61B | 219.20B | 266.32B | 211.48B | EBITDA |
370.73B | 457.57B | 446.38B | 471.68B | 447.69B | Net Income Common Stockholders |
254.48B | 215.18B | 182.69B | 202.70B | 160.04B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
342.14B | 355.90B | 484.02B | 481.83B | 451.86B | Total Assets |
3.51T | 3.27T | 3.33T | 3.19T | 3.19T | Total Debt |
245.68B | 211.18B | 285.32B | 316.32B | 405.57B | Net Debt |
-342.14B | -144.73B | -198.70B | -165.51B | -46.29B | Total Liabilities |
1.60T | 1.53T | 1.62T | 1.64T | 1.84T | Stockholders Equity |
1.75T | 1.59T | 1.59T | 1.45T | 1.24T |
Cash Flow | Free Cash Flow | |||
113.38B | 52.23B | 105.10B | 179.18B | 214.29B | Operating Cash Flow |
309.22B | 220.33B | 248.35B | 307.95B | 347.26B | Investing Cash Flow |
-157.24B | -42.81B | -59.27B | -71.56B | -114.21B | Financing Cash Flow |
-181.49B | -313.58B | -193.69B | -219.63B | -193.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $74.25B | 23.44 | 29.00% | 2.32% | 3.85% | -0.38% | |
77 Outperform | $191.14B | 25.19 | 27.26% | 1.88% | 4.10% | 9.78% | |
77 Outperform | $40.22B | 27.61 | 11.70% | 0.48% | -10.11% | -14.62% | |
76 Outperform | $38.30B | 16.36 | 16.61% | 1.56% | 4.09% | 14.05% | |
67 Neutral | $30.00B | 19.52 | 16.91% | 2.12% | -2.83% | 106.18% | |
60 Neutral | $10.94B | 10.48 | -7.04% | 2.99% | 7.55% | -12.20% | |
54 Neutral | $41.47B | 55.61 | 4.65% | 1.88% | -17.38% | ― |